To include your compound in the COVID-19 Resource Center, submit it here.

KD-295: Phase I started

The Kaketsuken Institute (Kumamoto, Japan), formerly the Chemo-Sero-Therapeutic Research

Read the full 92 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE